Collinsella Aerofaciens Test

Collinsella aerofaciens (C. aerofaciens) is a common member of the human gut microbiome, where it participates in carbohydrate metabolism and interacts closely with the gut lining and immune system. In healthy amounts, it is simply part of the diverse ecosystem that ferments dietary fibers and helps break down complex glycans, which are long carbohydrate chains found in many plant foods. The concern arises when its abundance becomes elevated. Higher levels of this bacterium are consistently linked to changes in metabolic health, gut barrier function, and inflammatory signaling.

C. aerofaciens appears to influence the permeability of the gut barrier. The gut barrier is a single-cell layer that regulates what can pass from the intestine into the bloodstream. Its integrity depends on structures called tight junction proteins that act like seals between cells. In several human and animal studies, increased C. aerofaciens is associated with reduced expression of these tight junctions. When this occurs, unwanted bacterial products can more easily enter the bloodstream. That movement of bacterial material into circulation is called metabolic endotoxemia. It is a well-recognized driver of chronic low-grade inflammation and is strongly tied to obesity, insulin resistance, and cardiovascular disease.

This bacterium also interacts with the immune system. Elevated levels are associated with increased activity of Th17 cells, which are a type of immune cell involved in autoimmune and inflammatory responses. Th17 expansion and the resulting pro-inflammatory cytokines, such as IL-17, are commonly elevated in rheumatoid arthritis and related autoimmune disorders. C. aerofaciens is found in greater abundance in people with rheumatoid arthritis, suggesting that its immune-activating effects may contribute to disease severity. However, it is still unclear whether C. aerofaciens is a driver of disease or whether its increase reflects an already-inflamed gut environment.

The metabolic effects of C. aerofaciens are especially relevant for a healthspan-focused audience. Multiple studies consistently show higher abundance in people with obesity, metabolic syndrome, type 2 diabetes, and nonalcoholic steatohepatitis. These metabolic conditions share overlapping features such as elevated insulin, higher triglycerides, and increased inflammation, all of which track with elevated C. aerofaciens. Diet plays an important role here. High fiber intake is associated with lower levels of this bacterium, while low fiber or high-fat dietary patterns tend to increase its presence. Because fiber is the main substrate for many beneficial short-chain-fatty-acid-producing bacteria, a low-fiber environment appears to selectively favor the expansion of C. aerofaciens at the expense of more anti-inflammatory species.

There is also evidence that C. aerofaciens affects bile acid metabolism. Bile acids are not only digestive detergents but also metabolic signaling molecules that influence lipid levels, glucose metabolism, and energy expenditure. Changes in bile acid transformation can alter these hormonal effects and potentially contribute to metabolic dysfunction. This may help explain why higher levels of this bacterium are linked to triglyceride and cholesterol abnormalities, as well as coronary artery disease.

Because C. aerofaciens is responsive to diet and microbiome-directed therapies, it is considered modifiable. Increasing dietary fiber, especially from diverse plant sources, generally reduces its abundance. Fecal microbiota transplantation has also been shown to shift its levels, especially in individuals with metabolic syndrome. Certain probiotic interventions may interact with C. aerofaciens as well. Notably, in irritable bowel syndrome, baseline levels of this bacterium may predict who will respond well to specific probiotic strains.

Overall, C. aerofaciens is not inherently harmful. It is a normal gut resident, but higher levels tend to reflect or contribute to an inflammatory, metabolically stressed environment. Because of its links to obesity, insulin resistance, autoimmune activation, and gut barrier dysfunction, it can serve as a useful microbiome marker of metabolic and immune stress, particularly in individuals focused on long-term health and disease prevention.